Number of shares outstanding for Haemonetics (HAE)

Number of shares outstanding as of December 2025 : 47,590,000

According to Haemonetics's latest financial reports and stock price the company's current number of shares outstanding is 47,590,000. At the end of 2025 the company had 47,590,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Haemonetics from 2012 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	47.59 M	-5.36%
2024	50.28 M	-0.95%
2023	50.76 M	0.51%
2022	50.5 M	-1.14%
2021	51.09 M	0.6%
2020	50.78 M	0.31%
2019	50.63 M	-1.5%
2018	51.4 M	-3.18%
2017	53.09 M	2.67%
2016	51.7 M	1.91%
2015	50.74 M	-1.34%
2014	51.43 M	-0.58%
2013	51.73 M	0.04%
2012	51.7 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Thermo Fisher Scientific TMO	378,000,000	694.28%	🇺🇸 USA
Stryker Corporation SYK	382,400,000	703.53%	🇺🇸 USA
Becton Dickinson BDX	287,170,000	503.43%	🇺🇸 USA
Cerus CERS	191,830,000	303.09%	🇺🇸 USA
Baxter BAX	514,000,000	980.06%	🇺🇸 USA
PerkinElmer PKI	126,285,000	165.36%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,195,000	4,956.09%	🇺🇸 USA
Medtronic MDT	1,281,600,000	2,593.00%	🇮🇪 Ireland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions